NEW AND TRADITIONAL SERUM MARKERS OF BONE METABOLISM IN THE DETECTIONOF SKELETAL METASTASES

Citation
M. Plebani et al., NEW AND TRADITIONAL SERUM MARKERS OF BONE METABOLISM IN THE DETECTIONOF SKELETAL METASTASES, Clinical biochemistry, 29(1), 1996, pp. 67-72
Citations number
25
Categorie Soggetti
Biology,"Chemistry Medicinal
Journal title
ISSN journal
00099120
Volume
29
Issue
1
Year of publication
1996
Pages
67 - 72
Database
ISI
SICI code
0009-9120(1996)29:1<67:NATSMO>2.0.ZU;2-B
Abstract
Objectives: The evaluation of ''new'' and ''traditional'' markers of o steoblastic and osteoclastic activity, in patients with bone metastase s. Design and Methods: Our series consist of 40 patients with clinical , radiological, and scintigraphic evidence of bone metastases, and 40 age-matched healthy subjects. In all samples, traditional markers were evaluated by measuring total alkaline phosphatase (ALP), tartrate-res istant acid phosphatase (TrACP) activity, and osteocalcin (BGP) concen tration. To assess new biochemical bone markers, bone isoenzyme of alk aline phosphatase (ALP-B) activity, carboxyterminal propeptide of type I procollagen (PICP), and carboxyterminal telopeptide of type I colla gen (ICTP) concentrations were measured. Results: Our findings showed that the best diagnostic efficiency is provided by ICTP (0.94) followe d by total ALP (0.90), ALP-B (0.80), and TrACP (0.76). The efficiency of BGP and PICP was, instead, very low (0.64 and 0.60, respectively). Conclusion: Our results confirm the utility of the new serum markers s uch as ALP-B and ICTP assays in detecting bone metastases.